WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today introduced the FDA Modernization Act 3.0, alongside bipartisan colleagues Reps. Nanette Barragán (D-CA), Vern Buchanan (R-FL), Rosa DeLauro (D-CT), Diana Harshbarger (R-TN), and Troy Carter (D-LA), a bill directing the FDA to fully implement provisions intended to reduce unnecessary animal testing for drug development.
This bill will require FDA to fully implement the FDA Modernization Act 2.0, signed into law in 2022, ensuring that safe and effective treatments are developed for patients using advanced and innovative non-animal testing methods.
“It is inhumane to rely solely on animal testing of medical products when other, harmless methods exist that are more predictive of human outcomes. The FDA Modernization Act 2.0, and recent actions by the Trump administration, have paved the way for modernizing FDA’s testing methods. This bill will put these wins into practice, accelerating innovation and getting safer, more effective drugs to market quickly by cutting unnecessary red tape,” said Rep. Buddy Carter.
“The FDA Modernization Act of 2021 was a monumental win that will streamline drug development and spur innovation without having to sacrifice at the expense of animal welfare,” said Rep. Vern Buchanan. “I look forward to building upon that success with Congressman Carter and ensuring the FDA follows through on delivering speedier cures for diseases without subjecting animals to inhumane and counterproductive experiments.”
“The FDA’s outdated animal testing rules are harming animals, hurting patients, and stalling medical innovation,” said Rep. Diana Harshbarger. “The FDA Modernization Act 3.0 will cut burdensome red tape to allow drug manufacturers to use modern and more humane alternatives to improve safety for animals and patients alike. As a compound pharmacist for more than 30 years, I understand that ensuring East Tennesseans have affordable access to safe medicines is of the utmost priority, and this bill is a step toward delivering safe medicines in a more humane way.”
“This bill will transform drug development for the 21st century. By requiring full implementation of the FDA Modernization Act 2.0, this legislation ensures that advanced, human-based testing methods are actively adopted in the drug development process. It’s a win for patients, a win for innovation, and a win for animal welfare. I’m proud to be join this bipartisan measure to accelerate safer, more humane, and more effective medical breakthroughs,” said Rep. Troy A. Carter, Sr.
Read full bill text here.
###
